BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24703231)

  • 21. Gamma-glutamylcysteine synthetase and L-buthionine-(S,R)-sulfoximine: a new selection strategy for gene-transduced neural and hematopoietic stem/progenitor cells.
    Lorico A; Bratbak D; Meyer J; Kunke D; Krauss S; Plott WE; Solodushko V; Baum C; Fodstad O; Rappa G
    Hum Gene Ther; 2005 Jun; 16(6):711-24. PubMed ID: 15960602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug metabolizing enzyme changes after chronic buthionine sulfoximine exposure modify acetaminophen disposition in rats.
    Manning BW; Franklin MR; Galinsky RE
    Drug Metab Dispos; 1991; 19(2):498-502. PubMed ID: 1676661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of glutathione synthesis as a chemotherapeutic strategy for leishmaniasis.
    Kapoor P; Sachdev M; Madhubala R
    Trop Med Int Health; 2000 Jun; 5(6):438-42. PubMed ID: 10929144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Buthionine sulfoximine inhibition of glutathione biosynthesis enhances hepatic lipid peroxidation in rats during acute ethanol intoxication.
    Kera Y; Ohbora Y; Komura S
    Alcohol Alcohol; 1989; 24(6):519-24. PubMed ID: 2576368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cysteine-dependent 5-S-cysteinyldopa formation and its regulation by glutathione in normal epidermal melanocytes.
    Benathan M; Labidi F
    Arch Dermatol Res; 1996 Oct; 288(11):697-702. PubMed ID: 8931873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. L-S,R-buthionine sulfoximine: historical development and clinical issues.
    Bailey HH
    Chem Biol Interact; 1998 Apr; 111-112():239-54. PubMed ID: 9679558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glutathione depletion by DL-buthionine-SR-sulfoximine (BSO) potentiates X-ray-induced chromosome lesions after liquid holding recovery.
    Bertsche U; Schorn H
    Radiat Res; 1986 Mar; 105(3):351-69. PubMed ID: 3754339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of buthionine sulfoximine treatment on diaphragm contractility and SR Ca2+ pump function in rats.
    Tupling AR; Vigna C; Ford RJ; Tsuchiya SC; Graham DA; Denniss SG; Rush JW
    J Appl Physiol (1985); 2007 Dec; 103(6):1921-8. PubMed ID: 17717121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene knockdown of gamma-glutamylcysteine synthetase by RNAi in the parasitic protozoa Trypanosoma brucei demonstrates that it is an essential enzyme.
    Huynh TT; Huynh VT; Harmon MA; Phillips MA
    J Biol Chem; 2003 Oct; 278(41):39794-800. PubMed ID: 12888552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aggravation of polycystic kidney disease in Han:SPRD rats by buthionine sulfoximine.
    Torres VE; Bengal RJ; Litwiller RD; Wilson DM
    J Am Soc Nephrol; 1997 Aug; 8(8):1283-91. PubMed ID: 9259355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Buthionine sulfoximine enhances glutathione-but attenuates glutamate-stimulated cell proliferation.
    Kang YJ
    Cell Mol Biol Res; 1995; 41(2):131-6. PubMed ID: 8581064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size transformation.
    Hamilos DL; Wedner HJ
    J Immunol; 1985 Oct; 135(4):2740-7. PubMed ID: 4031498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retroviral transfer of MRP1 and gamma-glutamyl cysteine synthetase modulates cell sensitivity to L-buthionine-S,R-sulphoximine (BSO): new rationale for the use of BSO in cancer therapy.
    Rappa G; Gamcsik MP; Mitina RL; Baum C; Fodstad O; Lorico A
    Eur J Cancer; 2003 Jan; 39(1):120-8. PubMed ID: 12504668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for embryonic peroxidase-catalyzed bioactivation and glutathione-dependent cytoprotection in phenytoin teratogenicity: modulation by eicosatetraynoic acid and buthionine sulfoximine in murine embryo culture.
    Miranda AF; Wiley MJ; Wells PG
    Toxicol Appl Pharmacol; 1994 Feb; 124(2):230-41. PubMed ID: 8122268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell cycle progression of glutathione-depleted human peripheral blood mononuclear cells is inhibited at S phase.
    Messina JP; Lawrence DA
    J Immunol; 1989 Sep; 143(6):1974-81. PubMed ID: 2789253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overproduction of Cu/Zn-superoxide dismutase or Bcl-2 prevents the brain mitochondrial respiratory dysfunction induced by glutathione depletion.
    Mérad-Saïdoune M; Boitier E; Nicole A; Marsac C; Martinou JC; Sola B; Sinet PM; Ceballos-Picot I
    Exp Neurol; 1999 Aug; 158(2):428-36. PubMed ID: 10415149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potentiation of arsenic trioxide cytotoxicity by Parthenolide and buthionine sulfoximine in murine and human leukemic cells.
    Duechler M; Stańczyk M; Czyz M; Stepnik M
    Cancer Chemother Pharmacol; 2008 Apr; 61(5):727-37. PubMed ID: 17594095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic activation of the Nrf2-signaling pathway by glyceollins under oxidative stress induced by glutathione depletion.
    Jung CL; Kim HJ; Park JH; Kong AN; Lee CH; Kim JS
    J Agric Food Chem; 2013 May; 61(17):4072-8. PubMed ID: 23573869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line.
    Armstrong JS; Steinauer KK; Hornung B; Irish JM; Lecane P; Birrell GW; Peehl DM; Knox SJ
    Cell Death Differ; 2002 Mar; 9(3):252-63. PubMed ID: 11859408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Importance of glutathione in the nodulation process of peanut (Arachis hypogaea).
    Bianucci E; Tordable Mdel C; Fabra A; Castro S
    Physiol Plant; 2008 Oct; 134(2):342-7. PubMed ID: 18485058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.